ANIMAL INTESTINAL HEALTH MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

The global animal intestinal health market has been witnessing significant growth in the recent years. Intestinal health plays a crucial role in overall animal well-being as it helps in the digestion of food and absorption of nutrients. Rising awareness about the importance of intestinal health and growing consumption of meat and dairy products have been driving owners to focus more on their pet's intestinal health. Moreover, the increasing prevalence of intestinal disorders among livestock and pets propels the need for effective feed additives and probiotics. Various industry players have been launching new products with probiotic formulations that help maintain a balance of gut microflora and enhance immunity. However, high costs associated with these specialized products restrict their adoption among budget-constrained owners.

Market Dynamics

The global animal intestinal health market is primarily driven by rising concerns about intestinal health among livestock and companion animals. Growing meat consumption worldwide has prompted farmers to focus on preventing intestinal issues that impact animal productivity. Additionally, increasing demand for dairy products is also compelling dairy farmers to ensure optimal gut health of their cattle herd. However, high costs associated with specialized feed additives and probiotic formulations remain a key challenge, especially in price-sensitive developing markets. On the other hand, growing pet ownership in emerging nations is widening the customer base. Further, ongoing innovations aimed at developing oral suspensions and chewable formulations are helping lower product costs, thereby creating new opportunities.

Key Features of the Study

• This report provides in-depth analysis of the global animal intestinal health market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global animal intestinal health market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Dsm-firmenich (DSM), Adisseo, Cargill, Evonik Industries, Kemin Industries, Alltech, Kerry Group plc., Novozymes A/S, Karyotica Biologicals Pvt Ltd., EW Nutrition, AB Vista, AdvaCarePharma, ADM, Zoetis, Boehringer Ingelheim, Dechra Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global animal intestinal health market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global animal intestinal health market

Market Segmentation

• Animal Type Insights (Revenue, USD Bn, 2020 - 2032)
• Production Animal
• Companion Animal
• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
• Nutrition
• Probiotics
• Prebiotics
• Postbiotics
• Phytogenics
• Enzymes
• Immunomodulators
• Pharmaceuticals
•  Form Insights (Revenue, USD Bn, 2020 - 2032)
• Dry
• Liquid
•  Application Insights (Revenue, USD Bn, 2020 - 2032)
• Metabolism
• Weight Gain
• Gut Health
• Nutrient Digestion
• Disease Prevention
• Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Dsm-firmenich (DSM)
• Adisseo
• Cargill
• Evonik Industries
• Kemin Industries
• Alltech
• Kerry Group plc.
• Novozymes A/S
• Karyotica Biologicals Pvt Ltd.
• EW Nutrition
• AB Vista
• AdvaCarePharma
• ADM
• Zoetis
• Boehringer Ingelheim
• Dechra Pharmaceuticals